LPL Financial
COCP icon

LPL Financial’s Cocrystal Pharma COCP Stock Holding History

LPL Financial’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,688
Closed -$130K – 4217
2021
Q4 		$130K Buy
16,688
+1,813
+12% +$18.6K ﹤0.01% 4080
2021
Q3 		$187K Buy
14,875
+2,083
+16% +$27.6K ﹤0.01% 4007
2021
Q2 		$192K Buy
12,792
+1,209
+10% +$18.4K ﹤0.01% 3912
2021
Q1 		$193K Buy
+11,583
New +$235K ﹤0.01% 3776

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LPL Financial's COCP Position: Q1 2022 in Review

LPL Financial sold out of Cocrystal Pharma (COCP) in Q1 2022, closing a stake of 16,688 shares — an estimated $130K sold.

LPL Financial first reported a position in COCP in Q1 2021 and held it in 4 quarters. The position peaked at $193K in Q1 2021. 34 funds tracked by Wall St. Rank hold COCP as of Q1 2022.

  • LPL Financial reported no remaining Cocrystal Pharma position as of Q1 2022 after selling out during the quarter.
  • LPL Financial sold 16,688 Cocrystal Pharma shares in Q1 2022, an estimated $130K.
  • LPL Financial first reported a position in Cocrystal Pharma in Q1 2021 and held it in 4 quarters.
  • LPL Financial's Cocrystal Pharma position peaked at $193K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2022.

Based on LPL Financial's 13F filing for Q1 2022, filed 16 May 2022.